DealRight, a block-chain based B2B marketplace enhanced with artificial intelligence that streamlines and integrates cross-border trade by providing secure, intelligent, and efficient global commerce solutions.

Our cross-border trading platform is your end-to-end trade partner - connecting you to the right sellers and buyers, enabling real-time payments and freight visibility, coordination and automation of logistics, and orchestrating custom payment and logistics solutions for a seamless global buying experience.

DealRight is more than a marketplace. It's the future of global trade - connected, intelligent, and borderless.

Accessing reliable, cost effective, and high-quality pharmaceuticals and medical supplies remains a significant challenge for nations, hospitals, and health care institutions worldwide. This issue is driven by a combination of complex factors - including cost volatility, logistical constraints, and the growing threat of counterfeit products.​​

​

1. High and Variable Costs

Many healthcare systems, especially in low and middle-income countries, struggle with the rising cost of essential medicines and medical supplies. Factors such as limited local manufacturing capacity, reliance on imports, currency fluctuations, and pricing disparities between regions contribute to significant procurement inefficiencies. In emergency situations, such as pandemics or natural disasters, prices often surge due to supply shortages and increased global demand.

​

2. Complex and Inefficient Logistics

The global supply chain for pharmaceuticals is highly fragmented and often lacks transparency. Cross-border restrictions, varying regulatory standards, cold chain requirements, and inconsistent transportation infrastructure can lead to delays, spoilage, and increased costs.

Hospitals and health institutions frequently face challenges tracking shipments, ensuring timely delivery, and maintaining the required storage conditions, particularly for temperature-sensitive products like vaccines and biologics.

​

3. Proliferation of Counterfeit and Substandard Products

One of the most critical threats to global health is the infiltration of counterfeit or substandard drugs into the supply chain. These products not only fail to treat the intended conditions but also contribute to antimicrobial resistance, treatment failures, and even fatalities. The World Health Organization estimates that one in ten medical products in low and middle-income countries is substandard or falsified. Weak regulatory oversight, lack of traceability, and the complexity of international supply chains exacerbate this problem.

​

The Need for a Secure, Transparent, and Efficient Sourcing Ecosystem

​

To address these challenges, there is an urgent need for a digital platform and technologies that can enable transparent sourcing, real-time tracking, cost benchmarking, and product authentication. 

We are launching DealRight Pharma to address the challenges encountered in the pharmaceutical industry.

DealRight Pharma will offer pharmaceutical solutions that integrate secure logistics, blockchain traceability, and AI-driven procurement intelligence that will empower health institutions to source more confidently - ensuring that patients receive safe, effective, and affordable healthcare.

​

DealRight Pharma aims to revolutionize pharmaceutical sourcing by directly addressing the critical challenges encountered in the global procurement process. By implementing a robust and transparent supply chain model, the company is committed to ensuring the highest standards of efficiency, cost-effectiveness, and regulatory compliance. Here's how DealRight Pharma will tackle the main challenges in sourcing pharmaceuticals worldwide:

​

1. Sourcing Generic Drugs Directly from Manufacturers

• Improve Pricing Transparency: By cutting out intermediaries, DealRight Pharma can offer more competitive prices, reflecting the true cost of production, and minimizing price inflation caused by third-party markups.

• Ensure Quality Assurance: Working directly with manufacturers allows DealRight Pharma to maintain strict oversight of production standards. The company will only partner with manufacturers that adhere to internationally recognized Good Manufacturing Practices (GMP), ensuring that all generic drugs meet the required quality and safety standards.

• Faster Time-to-Market: Direct sourcing also accelerates lead times, as it removes unnecessary layers in the supply chain, enabling quicker delivery of pharmaceutical products to global markets.

​

2. Traceability of Pharmaceuticals

Transparency and traceability are at the core of DealRight Pharma’s operations. The company will utilize cutting-edge technology, including blockchain and other digital tracking systems, to ensure the traceability of all products across the supply chain. This will:

• Combat Counterfeit Drugs: By ensuring that every product can be traced back to its original manufacturer, DealRight Pharma will significantly reduce the risk of counterfeit drugs entering the market, safeguarding public health.

• Enhance Regulatory Compliance: Global regulatory bodies, including the FDA and EMA, have increasingly stringent requirements for tracking the origin and movement of pharmaceutical products. By integrating robust traceability systems, DealRight Pharma will ensure compliance with these regulations, reducing the risk of fines, delays, or product recalls.

• Provide Transparency to Customers: Healthcare providers and patients alike will benefit from knowing exactly where and how their pharmaceuticals were sourced, which enhances trust in the DealRight Pharma brand.

​

3. Pricing Integrity

Ensuring fair and transparent pricing is crucial in the global pharmaceutical market. DealRight Pharma will:

• Standardize Pricing Models: Through direct partnerships with manufacturers and leveraging economies of scale, DealRight Pharma will offer competitive pricing that reflects the true value of the products, avoiding inflated prices typically associated with traditional procurement models.

• Offer Clear and Predictable Pricing: The company’s commitment to pricing integrity means that customers will receive consistent pricing, with no hidden fees or unexpected costs, even when sourcing from diverse global markets.

• Foster Long-Term Relationships: By offering consistent, transparent pricing, DealRight Pharma will build strong, long-term relationships with customers, reinforcing their reputation as a trusted global supplier of pharmaceuticals.

​

4. Customization of Medical Kits per Customer Requirements

DealRight Pharma understands that each customer has unique requirements, including specific pharmaceuticals and supplies, customs documentation, packaging, and labeling standards. To address these challenges, the company will:

• Offer Tailored Medical Kits: DealRight Pharma will create customized medical kits based on the specific customer needs. These kits will be designed to meet local regulatory requirements and optimize the supply chain for both delivery and customs clearance.

• Ensure Compliance with Local Regulations: By collaborating with local regulatory bodies, DealRight Pharma will ensure that all medical kits are compliant with national standards, avoiding delays at customs and ensuring smooth entry into the market.

• Streamline Logistics: The company will leverage its knowledge of global logistics to minimize the complexity of transporting medical kits internationally. This includes managing the preparation of necessary documentation, customs clearance, and meeting import/export regulations, all while reducing the potential for costly delays or errors.

​

Through a strategic focus on direct sourcing from reputable manufacturers, transparent traceability systems, pricing integrity, and customized medical kits, DealRight Pharma will overcome the challenges typically encountered in global pharmaceutical sourcing. By embracing technology, efficiency, and regulatory compliance, DealRight Pharma is positioned to become a leading player in the international pharmaceutical marketplace, delivering high-quality, affordable drugs to healthcare providers and patients around the world.

​

​

​

​

​

​

​

​

​

​

​​​

​

​